Increasing tumor thickness is associated with recurrence and poorer survival in patients with merkel cell carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 11, 2012, Pages 3325-3334

  Lim, Cathy S ^a,b,c   Whalley, Deborah ^a,i   Haydu, Lauren E ^d,e   Murali, Rajmohan ^d,e,h   Tippett, Jill ^f,g   Thompson, John F ^a,e   Hruby, George ^a,e   Scolyer, Richard A ^d,e  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d MELANOMA INSTITUTE AUSTRALIA   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f Symbion Laverty Pathology   (Australia)

^g Department of Microbiology and Infectious Diseases   (Australia)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; PROTEIN P63;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CELL NUCLEUS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISEASE SPECIFIC SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MERKEL CELL TUMOR; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN SURGERY; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LOWER EXTREMITY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; UPPER EXTREMITY;

EID: 84868215418     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2509-x     Document Type: Article

References (50)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107-10.
2. Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management. Cancer. 2007;110:1-12. (Pubitemid 46986412)
3. Hodgson NC. Merkel cell carcinoma: Changing incidence trends. J Surg Oncol. 2005;89:1-4. (Pubitemid 40075960)
4. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: Etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8(2):153-8. (Pubitemid 29085382)
5. Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection. Lancet. 2002;359:497-8. (Pubitemid 34164301)
6. Busam KJ, Jungbluth AA, Rekthman N, et al. Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol. 2009;33:1378-85.
7. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096-100. (Pubitemid 351300792)
8. Garneski KM, Warcola AH, et al. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol. 2009; 129:246-8.
9. Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: Prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300-9. (Pubitemid 46218722)
10. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: The AEIOU features. J Am Acad Dermatol. 2008;58:375-81. (Pubitemid 351226308)
11. Eng TY, Boersma MG, Fuller CD, et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol. 2007;30(6):624-36. (Pubitemid 350307189)
12. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. Merkel cell carcinoma. New York: Springer; 2010. 315-9.
13. Eng TY, Boersma MG, Fuller CD, et al. Treatment of merkel cell carcinoma. Am J Clin Oncol. 2004;27(5):510-5. (Pubitemid 39371950)
14. Pitale M, Sessions RB, Hussain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope. 1992;102:244-9.
15. Shaw JH, Rumball E. Merkel cell tumour: Clinical behaviour and treatment. Br J Surg. 1991;78:138-42.
16. Coit DG. Merkel cell carcinoma. Ann Surg Oncol. 2001;8(9 Suppl):99S-102S.
17. Suppl):99S-102S. 17. Skelton HG, Smith KJ, Hitchcock CL, et al. Merkel cell carcinoma: Analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol. 1997;37(5):734-9. (Pubitemid 27500317)
18. Llombart B, Monteagudo C, Lopez-Guerrero JA, et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology. 2005;46:622-34. (Pubitemid 40834821)
19. Mott RT, Smoller BR, Morgan MB. Merkel cell carcinoma: A clinicopathologic study with prognostic implications. J Cutan Pathol. 2004;31:217-23. (Pubitemid 38230563)
20. Asioli S, Righi A, Volante M, et al. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer. 2007;110: 640-7. (Pubitemid 47106154)
21. Carson HJ, Reddy V, Taxy JB. Proliferation markers and prognosis in Merkel cell carcinoma. J Cutan Pathol. 1998;25(1):16-9. (Pubitemid 28059590)
22. Feinmesser M, Halpern M, Fenig E, et al. Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: Can they predict treatment response and clinical outcome? Hum Pathol. 1999;30:1367-72. (Pubitemid 29534301)
23. Fernández-Figueras MT, Puig L, Musulén E, et al. Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod Pathol. 2007;20:90-101. (Pubitemid 44967954)
24. Kennedy MM, Blessing K, King G, Kerr KM. Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study. Am J Dermatopathol. 1996;18:273-7. (Pubitemid 26230852)
25. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg Oncol. 1970;172:902-8.
26. Kerfoot C, Huang W, Rottenberg SA. Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C alpha. J Histochem Cytochem. 2004;52(3):419-22. (Pubitemid 38229108)
27. Fields RC, Busam KJ, Chou JF, et al. Five hundred patients with merkel cell carcinoma evaluated at a single institution. Ann Surg. 2011;254(3):465-75.
28. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: Histologic features and prognosis. Cancer. 2008;113(9):2549-58.
29. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-206.
30. Thompson JF, Soong SJ, Balch CM, et al. The prognostic significance of mitotic rate in localized primary cutaneous melanoma: An analysis of patients in the multi-institutional AJCC melanoma staging database. J Clin Oncol. 2011;29:2199-205.
31. Fernández-Figueras MT, Puig L, Musulen E, et al. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma. Histopathology. 2005;46: 614-21. (Pubitemid 40834820)
32. Koljonen V, Tukiainen E, Haglund C. Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma. Histopathology. 2006;49(5):551-3. (Pubitemid 44631635)
33. Schmidt M, Janssen K, Dockhorn-Dworniczak B, et al. P53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis. Virchows Arch. 1997;430:233-7. (Pubitemid 27151934)
34. Asioli S, Righi A, de Biase D, et al. Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas. Mod Pathol. 2011;24:1451-61.
35. Allen PJ, Busam K, Hill AD, et al. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer. 2001;92:1650-5. (Pubitemid 32947851)
36. Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg. 1999;86:518-21. (Pubitemid 29195050)
37. Warner RE, Quinn MJ, Hruby G, et al. Management of merkel cell carcinoma: The roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol. 2008;15:2509-18.
38. Gupta SG, Wang LC, Penas PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142(6):685-90.
39. Mehrany K, Otley CC, Weenig RH, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg. 2002;28:113-7. (Pubitemid 34177347)
40. Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: A population-based study. J Cutan Pathol. 2010;37: 20-7.
41. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63(5):751-61.
42. Poulsen M, Round C, Keller J, et al. Factors influencing relapsefree survival in Merkel cell carcinoma of the lower limb - a review of 60 cases. Int J Radiat Oncol Biol Phys. 2010;76(2): 393-7.
43. Guler-Nizam E, Leiter U, Metzler G, et al. Clinical course and prognostic factors of Merkel cell carcinoma of the skin. Br J Dermatol. 2009;161(1):90-4.
44. Ng L, Beer TW, Murray K. Vascular density has prognostic value in Merkel cell carcinoma. Am J Dermatopathol. 2008;30:442-5.
45. Beer TW, Ng LB, Murray K. Mast cells have prognostic value in Merkel cell carcinoma. Am J Dermatopathol. 2008;30:27-30. (Pubitemid 351161626)
46. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007;25(9):1043-7. (Pubitemid 46596754)
47. Jabbour J, Cumming R, Scolyer RA, et al. Merkel cell carcinoma: Assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease - results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol. 2007;14(6):1943-52. (Pubitemid 46870931)
48. Eich HT, Eich D, Staar S, et al. Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol. 2002;25:50-6. (Pubitemid 34133952)
49. Medina-Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: Case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8:204-8. (Pubitemid 32294799)
50. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys. 1995;31: 315-23.